ABUS vs KR
Arbutus Biopharma Corp (ABUS) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the ABUS and KR stock pages for the full models.
Not investment advice.